06/26/2026 | Press release | Archived content
A company announces plans to go public, financial media coverage intensifies, and interest follows quickly. By that point, much of the value creation may already have occurred in private hands. That is what makes investing before the IPO so appealing to many accredited investors - and why it deserves careful scrutiny rather than enthusiasm alone.
For investors used to public markets, pre-IPO investing can appear to offer a simple advantage: earlier entry at a lower valuation. Sometimes that is true. Just as often, the reality is more complicated. Access is limited, company information is less standardized, liquidity can disappear for years, and a future IPO is never guaranteed. The opportunity can be compelling, but only when the structure, timing, and underwriting are sound.
Investing before the IPO generally refers to purchasing an ownership interest in a private company before its shares begin trading on a public exchange. That can happen during a late-stage growth round, through a structured vehicle that pools investor capital, or in certain cases through secondary transactions involving existing shareholders.
The phrase often gets used loosely, which creates confusion. Some investors think any private company investment is pre-IPO investing. In practice, there is a meaningful difference between backing an early venture-stage business and investing in a more mature company that may be approaching public markets. The risk profile, information quality, use of proceeds, and expected timeline can vary substantially.
A company discussing a potential public listing may still remain private for years. Market conditions shift. Revenue targets are missed. Profitability takes longer than expected. Regulatory issues emerge. Leadership changes priorities. A possible IPO can support the investment thesis, but it should not be the thesis by itself.
The attraction is straightforward. Private investors hope to participate in business growth before public-market pricing reflects broader demand. If a company scales revenue, improves margins, and reaches the public market at a higher valuation, early investors may benefit from that increase.
There are also portfolio construction reasons. For accredited investors with concentrated exposure to public equities, private growth investments can broaden return sources and reduce dependence on day-to-day market sentiment. That does not make them safer. It simply means they behave differently.
Still, discipline matters here. The best reason to consider investing before the IPO is not that a company is popular or recognizable. It is that the business demonstrates strong fundamentals, a credible operating plan, governance that can support scale, and a valuation that leaves room for reasonable returns after accounting for illiquidity and execution risk.
The most common mistake in this area is focusing on upside without pricing the constraints. Private shares are not freely tradable. Reporting is not as standardized as in public markets. Capital can be tied up for an extended period. Even when a company does go public, lock-up periods may delay any sale of shares.
Valuation is another challenge. In public markets, price discovery happens every day. In private markets, valuation is often based on the terms of the latest financing round, negotiated preferences, market comparables, and investor appetite at a specific moment. That can produce outcomes that look precise on paper but remain highly sensitive to assumptions.
There is also a structural issue many individual investors overlook. Not all shares are economically identical. Preferred securities may carry rights, protections, or liquidation preferences that common shareholders do not receive. If an investor accesses a company through a fund or special purpose vehicle, additional fees, terms, and governance layers may affect net outcomes.
This is why structure deserves as much attention as company quality. A strong business can still become a weak investment if the entry point is poor or the terms are misaligned.
A prudent review starts with the company, but it should not end there. Revenue quality matters. So do margins, customer concentration, retention, capital intensity, and the realism of management's growth assumptions. Investors should understand whether the company is using new capital to fund productive expansion, cover operating losses, or solve balance sheet pressure.
The next step is to examine the path to liquidity without assuming a public listing. Could the company attract strategic buyers? Is there a credible secondary market for future transactions? Does the business generate enough operating momentum to command continued investor support if public markets remain closed? A private investment should have a rationale that survives even if the IPO window does not open on schedule.
Governance is another essential element. Board composition, investor rights, financial controls, and reporting quality are not administrative details. They are part of risk management. In private markets, limited transparency increases the value of rigorous diligence and aligned oversight.
Experienced investors also pay close attention to the capitalization table. Future dilution can materially affect returns. If a company will likely require several additional rounds of capital before a potential listing, early ownership percentages may shrink meaningfully. In some cases, later financings happen at less favorable valuations, which can alter the economics for existing investors.
Pre-IPO opportunities tend to make more sense when a company is operationally mature, has a demonstrated market position, and no longer depends on highly speculative assumptions to justify its valuation. That does not mean the outcome is certain. It means the underwriting can rely more on evidence than optimism.
This type of investment may also fit investors who have a long time horizon and sufficient liquidity elsewhere in the portfolio. Capital that may be needed for near-term obligations should not be allocated to a vehicle where timing is uncertain. Private market exposure works best when it is sized appropriately within a broader allocation plan.
For many accredited investors, that means treating pre-IPO exposure as one component of a diversified private markets strategy rather than the centerpiece. Private credit, for example, often serves a very different role by emphasizing income generation, seniority in the capital structure, and downside protection. Growth equity may provide return potential, but it should be balanced against investments with clearer cash flow characteristics and more defined risk controls.
One misconception is that earlier always means better. It does not. Earlier entry may offer more upside, but it usually carries more business risk, less information, and a longer holding period. A later-stage investment at a disciplined valuation can sometimes produce a better risk-adjusted outcome than a much earlier investment in a less proven company.
Another misconception is that a recognizable brand signals investment quality. Consumer visibility can create confidence, but strong investing depends on economics, not familiarity. Investors should distinguish between a company that is well known and a company that is well underwritten.
There is also the belief that an eventual IPO solves most risks. In reality, public listing introduces a new set of variables. Market conditions at the time of listing, lock-up restrictions, public-market investor sentiment, and post-IPO execution all matter. A company can reach the public market and still deliver disappointing returns to private investors who entered at an inflated valuation.
The most effective way to approach investing before the IPO is with a private markets mindset, not a public markets mindset. That means underwriting the business, understanding the structure, evaluating downside cases, and accepting that liquidity is a negotiated event rather than a daily feature.
It also means asking plain, useful questions. What rights come with the investment? How is valuation being set? What happens if the company raises more capital? What are the likely exit paths besides an IPO? How concentrated is the position within the broader portfolio? If those answers are difficult to obtain or overly dependent on optimistic assumptions, restraint is often the better decision.
For investors who value clarity and process, this area can still play a role. But access alone is not an advantage. Structured access, informed due diligence, and disciplined sizing are what turn a private opportunity into a potentially sensible allocation.
The strongest private market decisions are rarely driven by urgency. They are built on alignment, patience, and a clear understanding of what must go right - and what could go wrong - before capital is committed.